Fluconazole therapy in neonatal candidemia

Y. C. Huang, T. Y. Lin, R. I. Lien, Y. H. Chou, C. Y. Kuo, P. H. Yang, W. S. Hsieh

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

We reviewed 62 episodes (from 59 infants) of neonatal candidemia that occurred between January 1994 and June 1999. Except 5 term babies, all infants were premature (median gestational age [GA], 30 weeks) and birth weight was less than 2500 g (median, 1300 g). Most infants had reported risk factors and other neonatal problems. The age at onset of candidemia ranged from 15 to 173 days with a median of 34 days. In addition to catheter removal, all but one infants received antifungal agents and candidemia was eradicated subsequently in 46 episodes (75%). Eighteen infants with 19 episodes ever received fluconazole therapy. Fluconazole was administered as the first line agent in 6 episodes and successfully cleared candidemia in 5 episodes. Fluconazole was used as an alternative agent in an additional 13 episodes after amphotericin B (am B) ± flucytosine were given for a period without a satisfactory result and eradication of candidemia was achieved in 8 episodes subsequently. All 18 infants tolerated fluconazole well and no withdrawal was required on account of its adverse effect. In contrast, am B alone was administered as the first line agent in 55 episodes and successfully cleared candidemia in 32 episodes (58%). This retrospective analysis suggests that fluconazole appears to be safe in neonates and can be used as an alternative agent in treating neonatal candidemia. A large-scaled prospective study may be needed.

Original languageEnglish
Pages (from-to)411-415
Number of pages5
JournalAmerican Journal of Perinatology
Volume17
Issue number8
DOIs
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Candidemia
Fluconazole
Amphotericin B
Therapeutics
Flucytosine
Antifungal Agents
Age of Onset
Birth Weight
Premature Infants
Gestational Age
Catheters
Newborn Infant
Prospective Studies

Keywords

  • Candidemia
  • Fluconazole
  • Neonate

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology

Cite this

Huang, Y. C., Lin, T. Y., Lien, R. I., Chou, Y. H., Kuo, C. Y., Yang, P. H., & Hsieh, W. S. (2000). Fluconazole therapy in neonatal candidemia. American Journal of Perinatology, 17(8), 411-415. https://doi.org/10.1055/s-2000-13454

Fluconazole therapy in neonatal candidemia. / Huang, Y. C.; Lin, T. Y.; Lien, R. I.; Chou, Y. H.; Kuo, C. Y.; Yang, P. H.; Hsieh, W. S.

In: American Journal of Perinatology, Vol. 17, No. 8, 2000, p. 411-415.

Research output: Contribution to journalArticle

Huang, YC, Lin, TY, Lien, RI, Chou, YH, Kuo, CY, Yang, PH & Hsieh, WS 2000, 'Fluconazole therapy in neonatal candidemia', American Journal of Perinatology, vol. 17, no. 8, pp. 411-415. https://doi.org/10.1055/s-2000-13454
Huang, Y. C. ; Lin, T. Y. ; Lien, R. I. ; Chou, Y. H. ; Kuo, C. Y. ; Yang, P. H. ; Hsieh, W. S. / Fluconazole therapy in neonatal candidemia. In: American Journal of Perinatology. 2000 ; Vol. 17, No. 8. pp. 411-415.
@article{2dc0709eab4e4b5c8fac720f8abaeb8d,
title = "Fluconazole therapy in neonatal candidemia",
abstract = "We reviewed 62 episodes (from 59 infants) of neonatal candidemia that occurred between January 1994 and June 1999. Except 5 term babies, all infants were premature (median gestational age [GA], 30 weeks) and birth weight was less than 2500 g (median, 1300 g). Most infants had reported risk factors and other neonatal problems. The age at onset of candidemia ranged from 15 to 173 days with a median of 34 days. In addition to catheter removal, all but one infants received antifungal agents and candidemia was eradicated subsequently in 46 episodes (75{\%}). Eighteen infants with 19 episodes ever received fluconazole therapy. Fluconazole was administered as the first line agent in 6 episodes and successfully cleared candidemia in 5 episodes. Fluconazole was used as an alternative agent in an additional 13 episodes after amphotericin B (am B) ± flucytosine were given for a period without a satisfactory result and eradication of candidemia was achieved in 8 episodes subsequently. All 18 infants tolerated fluconazole well and no withdrawal was required on account of its adverse effect. In contrast, am B alone was administered as the first line agent in 55 episodes and successfully cleared candidemia in 32 episodes (58{\%}). This retrospective analysis suggests that fluconazole appears to be safe in neonates and can be used as an alternative agent in treating neonatal candidemia. A large-scaled prospective study may be needed.",
keywords = "Candidemia, Fluconazole, Neonate",
author = "Huang, {Y. C.} and Lin, {T. Y.} and Lien, {R. I.} and Chou, {Y. H.} and Kuo, {C. Y.} and Yang, {P. H.} and Hsieh, {W. S.}",
year = "2000",
doi = "10.1055/s-2000-13454",
language = "English",
volume = "17",
pages = "411--415",
journal = "American Journal of Perinatology",
issn = "0735-1631",
publisher = "Thieme Medical Publishers",
number = "8",

}

TY - JOUR

T1 - Fluconazole therapy in neonatal candidemia

AU - Huang, Y. C.

AU - Lin, T. Y.

AU - Lien, R. I.

AU - Chou, Y. H.

AU - Kuo, C. Y.

AU - Yang, P. H.

AU - Hsieh, W. S.

PY - 2000

Y1 - 2000

N2 - We reviewed 62 episodes (from 59 infants) of neonatal candidemia that occurred between January 1994 and June 1999. Except 5 term babies, all infants were premature (median gestational age [GA], 30 weeks) and birth weight was less than 2500 g (median, 1300 g). Most infants had reported risk factors and other neonatal problems. The age at onset of candidemia ranged from 15 to 173 days with a median of 34 days. In addition to catheter removal, all but one infants received antifungal agents and candidemia was eradicated subsequently in 46 episodes (75%). Eighteen infants with 19 episodes ever received fluconazole therapy. Fluconazole was administered as the first line agent in 6 episodes and successfully cleared candidemia in 5 episodes. Fluconazole was used as an alternative agent in an additional 13 episodes after amphotericin B (am B) ± flucytosine were given for a period without a satisfactory result and eradication of candidemia was achieved in 8 episodes subsequently. All 18 infants tolerated fluconazole well and no withdrawal was required on account of its adverse effect. In contrast, am B alone was administered as the first line agent in 55 episodes and successfully cleared candidemia in 32 episodes (58%). This retrospective analysis suggests that fluconazole appears to be safe in neonates and can be used as an alternative agent in treating neonatal candidemia. A large-scaled prospective study may be needed.

AB - We reviewed 62 episodes (from 59 infants) of neonatal candidemia that occurred between January 1994 and June 1999. Except 5 term babies, all infants were premature (median gestational age [GA], 30 weeks) and birth weight was less than 2500 g (median, 1300 g). Most infants had reported risk factors and other neonatal problems. The age at onset of candidemia ranged from 15 to 173 days with a median of 34 days. In addition to catheter removal, all but one infants received antifungal agents and candidemia was eradicated subsequently in 46 episodes (75%). Eighteen infants with 19 episodes ever received fluconazole therapy. Fluconazole was administered as the first line agent in 6 episodes and successfully cleared candidemia in 5 episodes. Fluconazole was used as an alternative agent in an additional 13 episodes after amphotericin B (am B) ± flucytosine were given for a period without a satisfactory result and eradication of candidemia was achieved in 8 episodes subsequently. All 18 infants tolerated fluconazole well and no withdrawal was required on account of its adverse effect. In contrast, am B alone was administered as the first line agent in 55 episodes and successfully cleared candidemia in 32 episodes (58%). This retrospective analysis suggests that fluconazole appears to be safe in neonates and can be used as an alternative agent in treating neonatal candidemia. A large-scaled prospective study may be needed.

KW - Candidemia

KW - Fluconazole

KW - Neonate

UR - http://www.scopus.com/inward/record.url?scp=0034519034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034519034&partnerID=8YFLogxK

U2 - 10.1055/s-2000-13454

DO - 10.1055/s-2000-13454

M3 - Article

C2 - 11142391

AN - SCOPUS:0034519034

VL - 17

SP - 411

EP - 415

JO - American Journal of Perinatology

JF - American Journal of Perinatology

SN - 0735-1631

IS - 8

ER -